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Summary
The Introduction reviews human breast anatomy, biochemistiy and physiology of human
lactation, and human milk composition with emphasis on lipids and fatty acids (chapters
1.1 and 1.2). Present knowledge on perinatal fatty acid transport, parameters of essential
fatty acid (EFA) starus and the role of long chain polyunsaturated fatty acids (LCPUFA;
> Cro) in perinatal growth and development are discussed in the third part of the Introduc-
tion (chapter 1.3). The scope of the thesis was to contribute to various nutritional aspecrs
in the perinatal period, with emphasis on human milk composition, influence of maternal
diet and disease on human milk composition, and EFA and myoinositol in the perinatal
period.
Human lactation (chapter 1.1) comprises three major processes, i.e. l) lactogenesis (onset
of milk synthesis and secretion), 2) milk ejection and 3) galactopoeisis (continued milk
secretion). The underlying mechanisms are hormonally (notably prolactin and oxytocin)
and neurologically controlled. Human milk (chapter 1.2) volume and macronutrient
composition are not constant entities. They are influenced by factors such as gestational
age, maternal diet and duration of lactation. Lipids are the most variable milk constítuents.
They are the main energy source for the newborn, providing 40-50% of total energy.
Fatty acids, esterified as triglycerides, are the major lipid components. Adults metabolize
the (parent) EFA linoleic and a-linolenic acids by alternating chain-elongation and desatu-
ration, to produce LCPUFA. LCPUFA are structural components of cellular membranes
and serve as precursors for eicosanoid synthesis. LCPUFA play important roles in brain
development, especially in the last trimester of gestation and first months after birth, when
the brain growth spurt takes place. Fetus and newborn are unable to synthesis sufficient
LCPUFA to cover their demands. LCPUFA should. therefore. be considered essential in
the perinatal period. Low fetal LCPUFA status (chapter 1.3) is related to lower birth
weight and duration of gestation, whereas low neonatal LCPUFA status is related to
diminished visual acuity. LCPUFA status may be a factor in newborn growth, and
cognitive and neurological developments.
Chapter 2 concentrates on lipid and carbohydrate contents of mature human milk as
compared with current infant formulas (2.1), mature human milk fatty acid composition
(2,2), and mature human milk polyamine concentrations (2.3).
Human miik is the best sole nourishment for term infants in their first months after birth.
However, in circumstances where breastfeeding is not possible or undesired. human milk
substitutes remain necessary. Current formulas for term infants contain concentrations of
macronutrients and some important micronutrients comparable with mature human milk.
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There are, however, still marked differences in triglyceride species and micronutrient
composition. To establish to what extent current formulas for term infants differ in fatty
acid composition, sterols and minor carbohydrates, we investigated their contents in l0
currently available formulas tbr term babies (chapter 2.1). Results were compared with
data of 24 hour mature human milk from Dutch women, collected on postnatal days
14.4+3.5 (n:99) ,  42.1+2.7 (n:99)  and 89.2+5.6 (n:25) .  Mi lk  fa t ty  ac ids and srero ls
were analyzed as their methyl esters and trimethylsilyl ethers, respectively, using capillary
gas chromatography with flame ionization detection. Milk triglyceride concentlation was
calculated from its total fatty acid content. For analyses of lactose, monosaccharides and
sugaralcohols, milk was deproteinized and fur'ther prepurified by solid phase extraction.
Carbohydrates were determined as their trimethylsilyl ethers by capillary gas chromatog-
raphy with flame ionization detection. Formula triglyceride and lactose concentrations
were similar to those of human milk. Infant formulas and human milk did not diffèr in
polyunsaturated fatty acidisaturated fatty acid (PUFA/SAFA; P/S) ratio. Formula medium
fatty acid (MCFA: Cu-C,o) contents were generally higher (6 Íbrmulas), whereas LCPUFA
were considerably lower or undetectable (all formulas). Formula cholesterol concentrations
were 3-35 times lower, whereas phytosterol concentrations were much higher, compared
with human milk. Formula glucose (n:7), sorbitol (n=5) and myoinositol (all) concentra-
tions were generally lower, galactose was generally higher (n:9). whereas fucose and
eryth-reitol concentrations were in the lower mean*2SD human milk range. It is concluded
that fbrmula and human milk contain similar concentrations of fat and lactose. but that
they differ considerably in Íatty acid composition and concentrations of sterols, monosac-
charides and sugaralcohols. Literature data show that formula MCFA, either derived Íiom
coconut oil or semi synthetic medium chain triglycerides, do not augment newborn lipid
absorption, probably because of their deviant positions at the triglyceride glycerol
moieties. LCPUFA are considered essential in the perinatal period. Addition of LCPUFA
to Íbrmulas improves LCPUFA status of formula-fed preterm and term infants. Milk
cholesterol, phytosterol and P/S ratio intluence newborn cholesterol homeostasis.
Adequate cholesterol availability is important for newborn brain development. The
cholesterol challenge hypothesis postulates that early adaptation to high dietary cholesterol
intakes causes lower circulating cholesterol levels in adult life. High circulating myoinosi-
tol levels are associated with decreased incidence of bronchopulmonary dysplasia and
retinopathy in preterm inÍants with respiratory distress syndrome. Augmentation of infant
formula myoinositol concentration lmproves newborn myoinositol status. Biological
consequences of differences in other minor carbohydrates are as yet unclear.
Chapter 2.2 describes a study on PUFA and LCPUFA in mature human milk. Since
LCPLIFA are considered essential in the perinatal period, LCPUFA addition to infant
formulas, especially those for prematures, is advised. Human milk may serve as refer-
ence. Milk fatty acid composition is, however, dependent on maternal diet. We investiga-
ted (LC)PUFA balance in 24 hour milk from 99 lactating Dutch women, collected on
postnatal days 14 (n:99), 42 (n--99) and 89 (n:25). To estimate the influence of
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maternal diet, lbod intakes were recorded on postnatal days 12-14, 40-42 and 87-89. The
data revealed that linoleic acid (18:2o6) comprised 85% oï daily PUFA intake. Sixty-one
percent of the women did not consume fish, resulting in a median (range) daily fish intake
of 0 (0-56.8) g. Distributions of milk 20:3c,r6 and 20 4a6 were Gaussian, but those of
20:5a3 and 22:6a3 were right-skewed. Milk 20:5a3 and,22:6u3 were related. High milk
20:5a3 (>0.1 gi100 g) and22:6u3 (>0.4/100 g) were related to recent f ish consumpti-
on, rather than to milk 18:3<,13. Milk 20:3r.16 and,20:4a6 were not related to milk 18 2<':6
either. Literature data show that high formula l8:3o:3118:2c,:6 combined with addition of
20:5a3 and 22'.6u3 causes retarded growth, probably because of low infant 20:4c,r6 status.
However, milk from Inuit women and women following fish oil supplementation contains
much higher 20'.5or3 and 22:6or3 contents. The milk of these women may prevent low
neonatal 20 4a6 status due to low-normal 20 4a6 contents and normal L8'.3ci.3118:2a6
ratios. We conclude that formula l8:3a31782u6 and LCPUFA contents have to be
balanced to prevent low 20:4c06 status. From an evolutionary point of view, milk of
mothers on diets with high 18.2l'i,6 and low LCPUFAco3 may not be the ideal reÍ'erence Íbr
balanced addition of LCPUFA to formula.
In chapter 2.3 we studied longitudinal changes in marure human milk polyamine concen-
trations. The polyamines putrescine, and especially spermidine and spermine, are essential
tbr growth and development. They derive from de novo synthesis, from the diet and liom
the microbial flora in the gastrointestinal tract. It is suggested that dietary polyamines
stimulate gastrointestinal tract proliferation and maturation in newborns. Polyamine
concentrations in human milk and Íbrmula are highly variable. Putrescine concentrations
are comparable, whereas spermidine and spermine concentrations are about 10 times lower
in Íbrmulas compared with human milk. Twenty-four hour mature milk from Dutch
women was collected on days 14 (n=98), 42 (n=97) and 89 (n=25) after delivery.
Following a prepuritication step to remove milk fat, polyamines were determined by
capillary gas chromatography with nitrogen-phosphorous detection. In the observation
period, miik putrescine concentration did not change, whereas concentrations of spermi-
dine, spermine and total polyamines decreased. Because of incomplete milk collection, our
estimated 24 hour total polyamine milk outputs may be too low. Estimated median
newborn 24 hour total polyamine intake from mature milk corresponds with daily require-
ment for about 0.13-0.20 g mucosal tissue increment. This may be a significant amount,
notably when human milk polyamines function as a supplement to local polyamine de novo
synthesis. Putrescine, spermidine and spermine milk/plasma ratios are estimated to be 16-
19, 14-24 and 44-75, respectively. Nutrients with high milk/plasma ratios are usually
considered to fulfil biological functions in newborns. Milk polyamines may derive from
active uptake iiom plasma andlor de /rovo synthesis in the mammary gland. Our data
suggest that milk polyamines may have importance in newborn nutrition.
Chapter 3 describes the influence of maternal consumption of carbohydrate-rich diets on
milk total lipid and phospholipid Íatty acid composition (3.1) and the efÍèct of maternal
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vitamin E supplementation on milk vitamin E concentration (3.2). Milk from tightly
controlled patients with diabetes mellitus was investigated in chapter 3.3.
Chapter 3.1. concentrates on the influence of maternal diets with different carbohydrate
contents on incorporation of MCSAFA (6:0-14:0) into milk total lipids and phospholipid
subclasses. Milk MCFA are de novo synthesized from glucose in the mammary gland.
Women living in developing countries produce milk high in MCSAFA contents, due to
consumption of traditional carbohydrate-rich foods. We determined fatty acid compositions
of total lipids and isolated phospholipid subclasses from milk of women living in Domini-
ca and Belize. The minor milk phospholipid subclasses were separated from the bulk of
milk triglycerides by high performance liquid chromatography via a column-switching
technique. The total lipid fraction of Dominican milk showed higher relative amounts of
MCSAFA and 22:6o13 and lower amounts of long chain saturated fatty acids (LCSAFA)
and monounsaturated fatty acids (MUFA), compared with Belizian milk. Taking both
Dominican and Belizian milk data together, there was a positive relationship between the
MCSAFA content in total lipids and total phospholipids. Incorporation of MCSAFA in
phospholipids occurred at the expense of LCSAFA, MUFA, PUFA and LCPUFA.
Previous studies from Western countries revealed low amounts of MCSAFA and high
amounts of PUFA and LCPUFA in milk phospholipids. Our data show that carbohydrate-
rich diets give rise to incorporation of MCSAFA in phospholipids at the expense of PUFA
and LCPUFA. Incorporation of MCFA in all milk phosholipid subclasses uggests that
membranes of the lactating cell conserve their function, despite marked changes in fatty
acid composition. An alternative explanation is that, in contrast to general believe, milk
phospholipids are not derived from structural elements of the endoplasmatic reticulum,
Golgi vesicle membrane and apical cell membrane.
Chapter 3.2 describes the short term effect of maternal supplementation with o-tocopherol
on mature milk vitamin E concentrations. Since preterm infants are born with inadequate
vitamin E stores it is suggested that a-tocopherol supplementation may be beneficial to
both formula and human milk fed prematures. Superior c-tocopherol bioavailability from
human milk, compared with infant formula, results in a more optimal vitamin E status in
breastfed infants. We investigated the influence of a single dose of either 300 or 500 mg
d/-o-tocopherol acetate on 24 hour vitamin E blood-to-milk transfer kinetics and milk
recovery. The day before and after supplementation we collected mature milk from 6
lactating women. To study blood-to-milk o-tocopherol transport mechanism we additional-
ly determined o-tocopherol in plasma, erythocytes and platelets isolated from 2 lactating
women and 4 non-lactating controls subjected to the same protocol. o-Tocopherol
equivalents (o-TOC"o), triglycerides (TG), cholesterol (CHOL) and linoleic acid (18:2of)
were determined. Baseline plasma a-TOC"o and a-TOC"q/TG+CHOL showed, food
intake-related, diurnal variation. Following supplementation, plasma o-TOC.'/TG+CHOL
showed a, dose-independent, biphasic curve. There were no apparent differences in
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subjects. Plasma o-TOC"o did not show a dose-dependent relationship, whereas eryth-rocyte
and platelet a-TOC.o, and milk a-TOC"'/TG and c-TOC"olI82a6 showed gradual, dose-
dependent, increases. Twenty-four hour milk recoveries were 0.19 %, dose-independent,
and highly variable. Mammary gland vitamin E uptake may comprise several mechanisms.
Despite dietary intakes above recommendations for lactating women, presupplementation
24 hour a-TOC.o outputs of 0/6 women and a-TOC"o/18:2c,:6 of 3/6 met recommendations
for term newborns. In 24 hours following supplementation these criteria were met by 216
and 616, respectively. Recommended levels of a-TOC"o outputs may only be reached in
the second to third day following administration of a single oral dose and these levels can
be maintained during continuing supplementation. The data emphasize the important
intermediate role of adipose tissue in vitamin E distribution.
Insulin influences transmembrane fluxes of glucose and lipids, and activities of enzymes
involved in fatty acid chain-elongation/desaturation. Alterations in milk fatty acid
composition of women with insulin-dependent diabetes mellitus may, therefore, be
expected. In chapter 3.3 we investigated macro- and micronutrient compositions of milk
from six patients with tightly controlled insulin-dependent diabetes mellitus. Median
glycosylated hemoglobin at parturation was 5.2% (range: 4.9-5.3%; reference range:4.9-
6.6%) and 6.1% (range 5.0-6.3%, reference range 5.0-6.4%)l six weeks thereafter. The
results were compared with data from five healthy controls. Milk samples were collected
halfway through a single nursing at days 3-5 (colostrum),7,9,10 (transitional milk), and
12, 15, 17,2I,25,29,35 (mature milk). We found no abnormalit ies in macronutrient
(triglycerides, lactose, protein), cholesterol, glucose, and myoinositol concentrations, nor
in fatty acid composition. High milk glucose, as found in moderately and poorly control-
led patients, may be a reflection of mean blood glucose and the magnitude of paracellular
transport during the period of milk biosynthesis. From three longitudinally studied patients
in our study two showed rather constant ratios between glucose concentrations in milk and
capillary blood. The present data show that tight control of blood glucose concentrations
prevents the increase of milk glucose concentrations noted during moderate control, and
the multitude of milk abnormalities associated with poor control.
Chapter 4 describes studies on the origin of fetal LCPUFA (4.1) and parameters of
postnatal LCPUFA status (4.2). Effects of addition of ribonucleotides to infant formula on
newborn LCPUFA status (4.3), and different infant formula myoinositol concentrations on
newborn myoinositol status (4.4) were investigated.
In the study described in chapter 4.1 we concentrated on the origin of LCPUFA in the
newborn. For this, fatty acid compositions of plasma cholesterol esters and triglycerides of
38 singleton deliveries (23-42 weeks), 3 twins (32, 39 and 40 weeks) and their mothers
were investigated at birth. Very premature babies had high percentages free cholesterol in
plasma, which points at low lecithin:cholesterol acyltransferase activity. LCPUFA were
higher, and their precursors (18:2c,.r6 and 18:3<13) lower than those in maternal cholesterol
2t1
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esters and triglycerides. Trapping of LCPUFA by o-fetoprotein in the Íètal circulation
may be the main underlying cause. There were no gestational age dependent changes in
maternal tatt1, 2.i6 compositions. Except for 22:6a3, 20:2ia,6 and 22:5u6, all LCPUFA in
fetal triglycerides increased with advancing gestation. Fetal triglycertde 22:6a3122'.5li3
ratio decreased, whereas 22:5u6122:4<':6 remained constant. Increasing triglyceride
LCPUFA content with advancing gestation suggests partial derivation from Á6- and 45-
desaturase maturation in the liver. However, constancy of 22:6a3 and, 22:5a6122:4u6 and
decrease of 22:6a3122:5o3 in triglycerides point at low hepatic A4-desaturation. On the
basis of high postnatal erythrocyte 26:0 levels it is conceivable that low peroxisornal B-
oxidation is the underlying cause. Fetal cholesterol ester and triglyceride 20 3a9 contents
were higher than those of corresponding maternal Íiactions and did not change with
gestatioll. Transplacental transport of 20:3c,r9, followed by Í'etal conservation and to a
lesser degree fetal de nolo synthesis by 18:1<ir9 desaturation/chain elongation, should be
considered. Triglyceride l8:2a6 contents of premature and term babies were linearly
related to those of their mothers. Consequently, high 18:2<16 and low 18:3o3 intakes by
the mother may unfavourably intluence t-etal capacity to produce 22:6ra3 in the liver, due
to competition of parent essential fatty acids for desaturation. Because of low hepatic Á4-
desaturation capacity the inÍluence may, however, be small. Except for cholesterol ester
18:3c..,3, the heaviest baby of each twin had the highest EFA content in cholesterol esters
and triglycerides. Although the number of twins was small it suggests that low Íètal
essential fatty acid status is a limiting factor in growth.
LCPUFA contents of circulating lipids are used to monitor critical organ LCPUFA status
in the perinatal period. In chapter 4.2 we studied the possible usefulness of postnatal
plasma cholesterol esters and erythrocyte LCPUFA contents as indicators for LCPLIFA
status. Plasma cholesterol esters and erythrocytes were isolated Íiom seven lactating
wonren and their exclusively breastfed newborns, living on Dominica. In addition, we
studied mature milk fatty acid composition. Blood samples were taken from umbilical cord
and mother at birth. A sample of breastmilk was collected on day 20-22 postpartum,
together with a blood sample fiom the baby. Our results show that cord blood plasma
cholesterol ester and erythrocyte total LCPUFA contents were higher, and linoleic
(18:2a6) and c-linolenic (18:3013) acid contents lower, than in corresponding maternal
compartnents. PreÍèrential LCPUFA transport across the placenta is suggested and may
be accomplished by c-fetoprotein. Cord blood erythrocyte LCPUFAco3 content was lower
and LCPUFAo6 content higher than in maternal erythrocytes. After birth, f-eeding with
human milk led to a drop in plasma cholesterol ester LCPUFA content, whereas erythro-
cyte LCPUFA content remained virtually constant. DiÍÍerences in LCPUFA incorporation
efficacy in these compartments may be the underlying cause of the discrepancy. Plasma
cholesterol esters are Íbrmed by a transfer of a fatty acid from the sn-2 position of
phosphatidylcholine to free cholesterol, catalyzed by lecithin:cholesterol acyhransferase.
This enzyme has preference to transfer l8:2u6. It is conceivable that postnatal decrease in




















































































l8:2a6 content. In erythrocytes. the majority of LCPUFA are incorporated into
phosphatidylethanolamine and phosphatidylserine during erythropoiesis. Their incorporati-
on is hardly influenced by 18:2c06 intakes. Therefore, postnatal erythrocyte LCPUFA may
reflect I-CPUFA status of the bone marrow and may be a more reliable parameter fbr
LCPUFA status than plasma cholesterol ester LCPUFA content. Courses of erythrocyte
LCPUFA contents suggest hat at birth the newborn has lower LCPUFAo3 status than its
mother, and that this does not change during three weeks clf exclusive breastfeeding.
Whether lower LCPUFAc,:3 content in newborn erythrocytes ref'lects lower LCPUFAco3
status in brain, or derives from preferential deposition of these fatty acids in newborn
brain (0.'3 hierarchy) remains to be established.
Chapter 4.3 describes the eÍïect of ribonucleotide supplementation on LCPUFA status of
infant Íbrmula fed newborns. In newborns. conversion of 18:2c06 and 18:3c03 to LCPUFA
is insufficient to prevent postnatal LCPUFA decreases in several body compartmenls. It
has been suggested that supplementation of infant tbrmula with ribonucleotides induces
chain elongation and desaturation. We investigated whether ribonucleotide (RN) supple-
mentation of a regular fbrmula for premature infants (PRE: PRE+RN) raises erythrocyte
and plasma cholesterol ester LCPUFA of low-birth-weight babies ( < 2500 g) to levels
encountered in breastfed countelparts. From days 11 to 42. 31 babies received PRE and
3? PRE+RN. Eleven breastfed babies served as relèrence group. Erythrocyte and
cholesterol ester fatty acids were determined on days lL.2l and 42. There wele no
differences in erythrocyte and cholesterol ester Íatty acid courses of PRE and PRE+RN
fed babies. On day 42, formula-fed babies had lower erythrocyte and cholesterol ester
LCPUFA of both o3 and coó series, compared with breastfed babies. Subdivision into
gestational age and body weight matched subgroups gave similar results. We conclude that
ribonucleotide supplementation does not augment erythrocyte and cholesterol ester
LCPUFA status of formula-fed babies. LCPUFA supplementation of tbrmulas, notably
those for prenlatures, is indicated.
Myoinositol is a sugaralcohol that either occurs in its free form or as strucrural component
of membrane phospholipids. Free myoinositol may be an osmoregulator. Inositol phospho-
lipids play important roles in eicosanoid synthesis, signal transduction, growth, intracellu-
lar Caz* homeostasis and lipoprotein secretion. After birth. newborns have 3-6 times
higher myoinositol levels than adults. Adult levels are reached within 2-6 postnatal
months. Breastfed intants show slower myoinositol decreases than fornula Íèd counter-
parts. It is currently recommended to increase myoinositol concentrations in infant
formulas for prematures. In chapter 4.4 we studied the influence of different myoinositol
intakes Íiom intant formulas for prematures on plasma and erythrocyte myoinositol
conrents on postnatal days 10, 20 and 42. Thirty-four healthy low-birth-weight babies
(<2500 g) received infant formulas with low (PRE, 0.19 mmol/L; n:26) or high (PRE-,
1.24 mmol/L; n=8) myoinositol concentrations. Eleven breasttèd low-birth-weight







erythrocyte myoinositol were low in PRE-fed babies and comparably high in pRE+_ and
breastfed babies. In the milk myoinositol intake range of pRE and pRE*, plasma and
eryth-rocyte myoinositol exhibited non-linear dose-response r lations. In the intake range of
mature human milk to PRE+ they reach constant levels. In the 60-360 ltmollL plasma
myoinositol range plasma myoinositol determines erythrocyte myoinositol to a large
extent' Erythrocyte myoinositol may be regarded as a parameter of cellular myoinositol
availability, since erythrocytes contain a similar myoinositol active transport system. High
plasma myoinositol in newborns seems, therefore, necessary to accomplish high intracellu-
lar myoinositol. Following initiation of postdelivery urinary myoinositol loss the neonate
requires high myoinositol intakes to maintain high plasma myoinositol. Data from feeding
with PRE show that no compensatory augmentation of de novo synthesis or downregulati-
on of myoinositol disposal takes place. Early human milk myoinositol concentration is
higher than that in PRE*, and rapidly decreases below PRE* myoinositol concentration
with advancing lactation. PRE* myoinositol concentration may, therefore, be too low to
reach plasma levels similar to breastfed babies in the first postnatal days and may cause
higher myoinositol intakes than from human milk when PRE* feeding is continued for
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